ロード中...
CB(2) cannabinoid receptor activation promotes colon cancer progression via AKT/GSK3β signaling pathway
The pharmacological activation of the cannabinoid receptor type 2, CB(2), has been shown to elicit anti-tumoral mechanisms in different cancer types. However, little is known about its endogenous role in tumor pathophysiology, and different studies have attributed pro-tumorigenic properties to this...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5356589/ https://ncbi.nlm.nih.gov/pubmed/27634891 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11968 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|